Patients Take the Lead: WPA European Regional Meeting in Lisbon Drives New Era of NCD Care Transformation

WPA brings together patient leaders, global health organizations, and policymakers to advance patient voice and action in NCD prevention and care across Europe.

WASHINGTON , DC, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- The World Patients Alliance (WPA) successfully concluded its European Regional Meeting on November 1–2, 2025, in Lisbon, Portugal, under the theme “Empowering Patients, Transforming NCD Care in Europe: Strengthening patient advocacy, expanding access to care and advancing policy engagement to improve NCD outcomes.”

The landmark meeting brought together leading patient advocates, policymakers, health professionals, and international partners from across Europe to advance the role of patients in addressing the growing burden of Noncommunicable Diseases (NCDs) and in shaping equitable, patient-centered healthcare systems.

“The Lisbon meeting reaffirms that patients must be at the heart of health system transformation,” said Andrew Spiegel, Chair of the World Patients Alliance. “Empowering patients is essential not only for better care outcomes but also for building resilient, sustainable, and inclusive health systems in Europe and beyond.”

Key Highlights of the Meeting
Over two days, the program featured seven thematic sessions, plenary presentations, and interactive panel discussions focusing on key dimensions of NCD prevention, care and advocacy.

Key sessions included:
• UN High-Level Meeting Declaration
• Patient-Centered Care in NCDs
• Self-Care for Physical and Mental Wellbeing
• Patient Safety in NCD Management
• Prevention and Early Detection of NCDs in Europe
• E-Health, Telemedicine and AI in NCD Management
• Policy and Advocacy for NCDs

Participants explored the implications of these discussions for European healthcare systems, with speakers and panelists offering regional insights, policy frameworks and practical solutions for improving access, quality and safety of care.

A major highlight of the meeting was the launch of the Institute for Patient Safety & Research at the University of Kalisz, Poland, marking a significant milestone in advancing evidence-based, patient-led research and innovation across Europe.


Driving Regional Change with Global Support
The meeting underscored WPA’s commitment to embedding patient voices into national and regional health strategies. Representatives from the World Health Organization (WHO), International Pharmaceutical Federation (FIP), and numerous European national level advocacy groups participated in the discussions, emphasizing the urgent need for patient inclusion at every level of health policy and decision-making.

Presentations and dialogues introduced new frameworks for digital health integration, patient-centered safety protocols, and regional alignment of NCD policies, while highlighting persistent challenges in access, health literacy, and equity and showcasing success stories from patient organizations driving innovation and policy change across Europe.

Towards Better NCD Outcomes and the Future of Healthcare in Europe
Insights from the Lisbon Regional Meeting will inform WPA’s ongoing efforts under the Global Patient Agenda 2030, complementing international frameworks including the WHO Global Patient Safety Action Plan 2021–2030, the UN High Level Declaration on NCDs, and the European Health Union priorities.

The discussions in Lisbon underscored that patients are not passive participants in healthcare, they are active partners shaping the present and future of health systems. By uniting patient voices, policymakers, and health leaders, the meeting reaffirmed that empowering patients is fundamental to achieving better NCD outcomes, stronger health systems, and greater equity in care across Europe.

The shared lessons from the meeting will guide WPA’s ongoing advocacy, research, and capacity building efforts, fostering collaborative patient networks and accelerating policy transformation to advance patient-centered healthcare across the region and beyond.

Acknowledgements
The World Patients Alliance extends its sincere appreciation to all participants, speakers, and partners whose contributions made the Lisbon meeting a resounding success. Special thanks are extended to our Silver Sponsor, Boehringer Ingelheim, and Bronze Sponsor, The Association of the European Self-Care Industry (AESGP), whose generous support made this event possible. Their commitment to collaborative healthcare innovation reflects a shared vision for a more inclusive, patient-driven, and equitable healthcare future for all Europeans.

About the World Patients Alliance
The World Patients Alliance (WPA) is the largest global umbrella organization representing over 700 patient organizations from more than 130 countries. It advocates for the rights and interests of millions of patients worldwide, fostering collaboration, advocacy, and tangible improvements in healthcare systems.

Hussain Jafri, CEO
World Patients Alliance
+1 267-271-9314
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.